Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation

Prior treatment

• Patient currently participating or having participated in the month prior to inclusion in another clinical interventional research study that may have an impact on the study, this impact is left to the discretion of the investigator

Age

• Pregnant women (for women of childbearing age and in the absence of reliable contraception, the β-HCG (human chorionic gonadotropin) assay will be performed), parturient women, breastfeeding women,

Other

• Patient not available or wishing to change region within 3 months of inclusion
• Persons referred to in articles L1121-5 to L1121-8 of the French Public Health Code (corresponding to all protected persons)
• persons deprived of their liberty by judicial or administrative decision,
• persons under legal protection

• Patient with a diagnosis of ALS coming for a follow-up consultation with their pneumologist
• Daily NIV compliance of more than 4 hours in the month prior to inclusion
• Living at home
• Patient with a natural caregiver
• Patient equipped with computer equipment adapted for teleconsultation (tablet, computer, telephone... with an internet connection)
• Patient able to read and understand the procedure, and able to express consent for the study protocol
• Patient, or his or her caregiver, able to sign the consent to participate by himself or herself